Results 231 to 240 of about 5,459 (278)
Consumer behaviour towards counterfeit drugs in a developing country [PDF]
Journal of Pharmaceutical Health Services Research, 2012 Introduction Availability of counterfeit drugs is increasing, especially in developing countries. This fact makes it critical to develop new measures that can help to combat this problem.
Hassali Ma +2 more
exaly +2 more sources
Smart contract diffusion in the pharmaceutical blockchain: the battle of counterfeit drugs [PDF]
Journal of Business Research, 2023 Counterfeit drugs have long been a major concern. In search of a solution, this study conducted a systematic literature review. Using an automated content analysis of pharmaceutical blockchains, this study identifies the (1) unique characteristics of ...
Rana Mostaghel
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug counterfeiting and decentralized whistleblowers
Drug Discovery Today, 2022To tackle the devastating issue of drug counterfeiting, the US Food and Drug Administration (FDA) has initiated a pilot project in which 24 companies in the pharmaceutical supply chain use blockchain technology to track and trace drug deliveries among manufacturers, distributors, hospitals, clinics, and pharmacies.
Hossein, Omidian, Yadollah, Omidi
openaire +2 more sources
International Journal of Pharmaceutical Medicine, 2005
Recent literature suggests that drug counterfeiting is not just a national but also an international concern, affecting health policy makers, drug manufacturers, wholesalers, drug enforcement agents, healthcare providers and patients across the globe. It is also clear that counterfeiting is not limited to the least developed nations but is increasingly
Albert I. Wertheimer, Thomas M. Santella
openaire +1 more source
Recent literature suggests that drug counterfeiting is not just a national but also an international concern, affecting health policy makers, drug manufacturers, wholesalers, drug enforcement agents, healthcare providers and patients across the globe. It is also clear that counterfeiting is not limited to the least developed nations but is increasingly
Albert I. Wertheimer, Thomas M. Santella
openaire +1 more source
Counterfeit drugs: an Australian perspective
Medical Journal of Australia, 2016Past use-by date or poor packaging Reduced efficacy Ahighlighted the global impact of falsified or substandard drugs. In countries with stringent legislation, governance and customs, such as Australia, the prevalence of counterfeit medications is low and estimated by the World Health Organization to be less than 1% of market value.
Conor C, Hensey, Amanda, Gwee
openaire +2 more sources
PharmaCrypt: Blockchain for Critical Pharmaceutical Industry to Counterfeit Drugs [PDF]
Computer, 2020 This research analyzes the impact of counterfeit drugs on the health-care supply chain industry and evaluates the solutions currently in place to reduce the number of counterfeits coming to the market.
Prosanta Gope +2 more
exaly +3 more sources
Reducing Counterfeit Drugs with Blockchains: A Survey
2021 International Conference on Information Technology (ICIT), 2021Blockchain (BC) technology has revealed unusual opportunities to reduce fraud in the pharmaceutical, food and electrical equipment’s, industries. Specifically, the attractive features of blockchain technology, such immutability, decentralization, distribution, and transparency, can address the issues of trustless between parties, tracking and ...
Abdullah Quzmar +2 more
openaire +1 more source
Identifying and combating counterfeit drugs
Expert Review of Clinical Pharmacology, 2008What used to be a minor problem in distant lands, the sale of counterfeit drugs, is today a real problem in western Europe and North America, especially as drug prices have increased and the counte...
openaire +2 more sources